Navigation Links
Genzyme acquistion of Bone Care approved, significant impact forecast

Madison, Wis. - One of Wisconsin's most prominent pharmaceutical companies has been purchased, its stock delisted and its name changed. This move will result in a continued limited presence in Wisconsin, but could also create potential opportunites for the state's life science industry, increase distribution of their drug and has returned significant cash for the firm's investors.

......

Full article >>> company, those Bone Care employees not retained by Genzyme will be offered severance and outplacement assistance to help them transition to new employment.

Quinn said that while the company hopes to keep more than half of the existing staff - mostly in the sales and quality control divisions - executive positions will likely be offered severance packages.

"Since a lot of those po......

Full article >>> d the deals are usually successful for both parties. If a company as successful as Bone Care is purchased in Wisconsin it may help to draw more interest to the state, and having a large company like Genzyme holding office in the state could also help the industry get more momentum.

"The bottom line is we're hopeful the employee base remains in Dane County, but we're not in despair because......

Full article >>> hink this will set them up well for when they finally get a label for Renagel in the pre-dialysis market," Raymond said.......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 07/01/05


Related biology technology :

1. Cytochroma settles lawsuit with Genzyme
2. Genzyme sues former Bone Care employees
3. Emerging technology companies receive significant funding
4. Proposed telecom bill would have Katrina impact
5. Shades of gray: Business impacts of an aging workforce
6. Javas undeniable impact on the Web
7. The flattening world and its impact on U.S. biotech
8. Doyle signs bill that impacts electronic medical records
9. RFID starting to make real impact on business
10. Transition continues to impact Third Wave financials
11. The impact of ACT 255 on the future of high-tech investment in Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... of the QB3@953 life sciences incubator to ... health. The shared laboratory space at QB3@953 was created ... a key obstacle for many early stage organizations - ... of the sponsorship, Amgen launched two "Amgen Golden Ticket" ...
Breaking Biology Technology:
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):